Multisite Thrombosis in a Patient with Paroxysmal Nocturnal Hemoglobinuria
Beckmann L, Faizy T, Flottmann F, Fiehler J, Bokemeyer C, Well L, Beitzen-Heineke A, Langer F
HAMOSTASEOLOGIE. 2024.

Long-term cardiotoxicity in germ cell cancer survivors after platinum-based chemotherapy: cardiac MR shows impaired systolic function and tissue alterations
Beitzen-Heineke A, Rolling C, Seidel C, Erley J, Molwitz I, Muellerleile K, Saering D, Senftinger J, Börschel N, Engel N, Bokemeyer C, Adam G, Tahir E, Chen H
EUR RADIOL. 2024;34(6):4102-4112.

Left ventricular diastolic filling patterns in competitive triathletes with and without myocardial fibrosis by cardiac magnetic resonance time-volume analysis
Chen H, Jungesblut J, Saering D, Muellerleile K, Beitzen-Heineke A, Harms P, Erley J, Schoennagel B, Schneider J, Cavus E, Fischer R, Lund G, Adam G, Tahir E
EUR J RADIOL. 2023;158:.

Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase
Langer F, Quick H, Beitzen-Heineke A, Janjetovic S, Mäder J, Lehr C, Bokemeyer C, Kuta P, Renné T, Fiedler W, Beckmann L, Klingler F, Rolling C
THROMB RES. 2023;229:155-163.

Purpura Fulminans Triggered by the Formation of Anti-Endothelial Autoantibodies in a Patient with Chronic Lymphocytic Leukemia
Beckmann L, Lennartz M, Beitzen-Heineke A, Voigtländer M, Rolling C, Holstein K, Bokemeyer C, Amirkhosravi A, Langer F
Ann Hematol Oncol. 2022;9(1):.

Kardiale Nebenwirkungen antineoplastischer Substanzen
Beitzen-Heineke A, Bokemeyer C
2022. Kardio-Onkologie. Bokemeyer C, Lehmann L, Müller O (Hrsg.). 1. Aufl. De Gruyter, 179-196.

Kardiovaskuläre Langzeitüberwachung nach Krebstherapie
Beitzen-Heineke A, Bokemeyer C
2022. Kardio-Onkologie. Bokemeyer C, Lehmann L, Müller O (Hrsg.). 1. Aufl. De Gruyter, 219-228.

Acute impact of an endurance race on biventricular and biatrial myocardial strain in competitive male and female triathletes evaluated by feature-tracking CMR
Chen H, Warncke M, Muellerleile K, Saering D, Beitzen-Heineke A, Kisters A, Swiderska M, Cavus E, Jahnke C, Adam G, Lund G, Tahir E
EUR RADIOL. 2022;32(5):3423-3435.

Regulation of bone homeostasis by MERTK and TYRO3
Engelmann J, Zarrer J, Gensch V, Riecken K, Berenbrok N, Luu T, Beitzen-Heineke A, Vargas-Delgado M, Pantel K, Bokemeyer C, Bhamidipati S, Darwish I, Masuda E, Burstyn-Cohen T, Alberto E, Ghosh S, Rothlin C, Hesse E, Taipaleenmäki H, Ben Batalla I, Loges S
NAT COMMUN. 2022;13(1):.

Kardioonkologie – was leistet die MRT? : Inflammation, Fibrose, Outcome
Erley J, Beitzen-Heineke A, Tahir E
RADIOLOGIE. 2022;62(11):941-946.

Myocardial injury detected by T1 and T2 mapping on CMR predicts subsequent cancer therapy-related cardiac dysfunction in patients with breast cancer treated by epirubicin-based chemotherapy or left-sided RT
Tahir E, Azar M, Shihada S, Seiffert K, Goy Y, Beitzen-Heineke A, Molwitz I, Muellerleile K, Stehning C, Schön G, Adam G, Petersen C, Müller V, Lund G
EUR RADIOL. 2022;32(3):1853-1865.

Kardiale Toxizität antineoplastischer Substanzen
Alsdorf W, Beitzen-Heineke A, Schmid P, Suter T, Bokemeyer C
2021.

AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms
Beitzen-Heineke A, Berenbrok N, Waizenegger J, Päsler S, Gensch V, Udonta F, Vargas-Delgado M, Engelmann J, Hoffmann F, Schafhausen P, von Amsberg G, Riecken K, Beumer N, Imbusch C, Lorens J, Fischer T, Pantel K, Bokemeyer C, Ben Batalla I, Loges S
HEMASPHERE. 2021;5(9):.

Loss of CD22 expression and expansion of a CD22dim subpopulation in adults with relapsed/refractory B-lymphoblastic leukaemia after treatment with Inotuzumab-Ozogamicin
Reinert J, Beitzen-Heineke A, Wethmar K, Stelljes M, Fiedler W, Schwartz S
ANN HEMATOL. 2021;100(11):2727-2732.

Human Invariant Natural Killer T cells possess immune-modulating functions during Aspergillus infection
Beitzen-Heineke A, Bouzani M, Schmitt A, Kurzai O, Hünniger K, Einsele H, Loeffler J
MED MYCOL. 2015;54(2):169-176.

Letzte Aktualisierung aus dem FIS: 23.12.2024 - 23:36 Uhr